212 related articles for article (PubMed ID: 2934356)
1. The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors.
Uehara N; Baba H; Nitta K; Kunimoto T; Takeuchi M; Sasaki T; Tanaka T
Jpn J Cancer Res; 1985 Oct; 76(10):1034-41. PubMed ID: 2934356
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of a new fluoropyrimidine derivative, 5'-deoxy-5-fluorouridine, against murine and human experimental tumors.
Fujimoto S; Wang Y; Inoue K; Ogawa M
Jpn J Cancer Res; 1985 Jul; 76(7):644-50. PubMed ID: 3161854
[TBL] [Abstract][Full Text] [Related]
3. Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.
Ishitsuka H; Miwa M; Takemoto K; Fukuoka K; Itoga A; Maruyama HB
Gan; 1980 Feb; 71(1):112-23. PubMed ID: 6445847
[TBL] [Abstract][Full Text] [Related]
4. Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
Ooi A; Ohkubo T; Higashigawa M; Kawasaki H; Kakito H; Kagawa Y; Kojima M; Sakurai M
Biol Pharm Bull; 2001 Nov; 24(11):1329-31. PubMed ID: 11725974
[TBL] [Abstract][Full Text] [Related]
5. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with radiation therapy in mice bearing colon 26 adenocarcinoma.
Ishikawa T; Tanaka Y; Ishitsuka H; Ohkawa T
Jpn J Cancer Res; 1989 Jun; 80(6):583-91. PubMed ID: 2527217
[TBL] [Abstract][Full Text] [Related]
6. [Comparative studies on the antitumor activity of the fluorinated pyrimidines 5'-DFUR, tegafur, UFT and FUra on various murine tumors].
Miwa M; Eda H; Fukuda H; Fujimoto K; Ishitsuka H
Gan To Kagaku Ryoho; 1988 May; 15(5):1755-63. PubMed ID: 2967051
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor effects of 5'-deoxy-5-fluorouridine (5'-DFUR) against various murine tumors in combination with recombinant interferon alpha or cytostatics].
Ninomiya Y; Miwa M; Fukuda H; Ishikawa T; Eda H; Matsuura N; Tanaka Y; Ishitsuka H
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3271-7. PubMed ID: 2961305
[TBL] [Abstract][Full Text] [Related]
9. [Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice].
Miwa M; Sekiguchi F; Akaza H; Tokita H; Nitta K; Adachi S; Kanazawa K; Ishitsuka H
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1579-86. PubMed ID: 1831339
[TBL] [Abstract][Full Text] [Related]
10. [Conversion of 5'-deoxy-5-fluorouridine to 5-FU by pyrimidine nucleoside phosphorylases in normal and tumor tissues from rodents bearing tumors and cancer patients].
Miwa M; Nishimura J; Kamiyama T; Ishitsuka H
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2924-9. PubMed ID: 2959206
[TBL] [Abstract][Full Text] [Related]
11. Tissue distribution of 5'-deoxy-5-fluorouridine and derived 5-fluorouracil in tumor-bearing mice and rats.
Suzuki S; Hongu Y; Fukazawa H; Ichihara S; Shimizu H
Gan; 1980 Apr; 71(2):238-45. PubMed ID: 6451469
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in a variety of experimental tumors.
Hoshi A; Iigo M; Nakamura A; Yoshida M; Kuretani K
Gan; 1976 Oct; 67(5):725-31. PubMed ID: 1017587
[TBL] [Abstract][Full Text] [Related]
13. Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents.
Fujii S; Kitano S; Ikenaka K; Shirasaka T
Gan; 1979 Apr; 70(2):209-14. PubMed ID: 381088
[TBL] [Abstract][Full Text] [Related]
14. Differential selectivity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in cultured human B lymphocytes and mouse L1210 leukemia.
Au JL; Rustum YM; Minowada J; Srivastava BI
Biochem Pharmacol; 1983 Feb; 32(3):541-6. PubMed ID: 6221728
[TBL] [Abstract][Full Text] [Related]
15. Studies on the metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil co-administered orally to tumor-bearing rats.
Kawaguchi Y; Nagayama S; Masuda H; Yasuda A
Gan; 1980 Dec; 71(6):889-99. PubMed ID: 6791982
[TBL] [Abstract][Full Text] [Related]
16. [Effect of cepharanthine on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207)--5-fluorouracil delivery into tumor tissue].
Ono M
Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1379-92. PubMed ID: 2509603
[TBL] [Abstract][Full Text] [Related]
17. [Effects of 5'-deoxy-5-fluorouridine on human gastrointestinal and breast cancers xenografted to nude mice].
Fujita F; Fujita M; Taguchi T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1635-43. PubMed ID: 6236751
[TBL] [Abstract][Full Text] [Related]
18. Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5'-deoxy-5-fluorouridine against adenocarcinoma 755 in mice. Correlation with pharmacokinetics of plasma 5-fluorouracil levels.
Iigo M; Nishikata K; Nakajima Y; Hoshi A; Okudaira N; Odagiri H; De Clercq E
Biochem Pharmacol; 1989 Jun; 38(12):1885-9. PubMed ID: 2525905
[TBL] [Abstract][Full Text] [Related]
19. [A new anticancer drug, 5'-deoxy-5-fluorouridine (5'-DFUR)].
Tsukagoshi S
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2977-82. PubMed ID: 2959207
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of 5'-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs.
Nio Y; Kimura H; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Meyer C; Fukumoto M; Tobe T
Anticancer Res; 1992; 12(4):1141-6. PubMed ID: 1386969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
